Esperion Therapeutics Inc (ESPR)

Dec 31, 2025

Is Esperion Therapeutics Inc a good long term investmentGlobal Trade Effects & Free Rapid Wealth Building - earlytimes.in

Dec 31, 2025

Dec 30, 2025

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8%Time to Sell? - MarketBeat

Dec 30, 2025

Dec 28, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 28, 2025

Dec 26, 2025

PFE6265887 Bond Coupon Analysis — Rate & Payments - TradingView — Track All Markets

Dec 26, 2025

Dec 23, 2025

Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week HighTime to Buy? - MarketBeat

Dec 23, 2025

Dec 20, 2025

Is Esperion Therapeutics Inc. stock attractive for long term wealth buildingPortfolio Update Summary & Real-Time Volume Triggers - Улправда

Dec 20, 2025

Dec 19, 2025

Will Esperion Therapeutics Inc. stock split attract more investorsJuly 2025 Intraday Action & Weekly High Return Stock Forecasts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Esperion Therapeutics Inc. (0ET) stock compares with top peersQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Esperion’s Bempedoic Acid Receives Recommendation in 2025 ACC Scientific Statement on Management of Peripheral Artery Disease in Adults With Diabetes - The Manila Times

Dec 19, 2025

Dec 19, 2025

Esperion's Bempedoic Acid Recognized by ACC as Effective LDL-C Lowering Therapy for Patients with PAD and Diabetes - Quiver Quantitative

Dec 19, 2025

Dec 19, 2025

Esperion’s Bempedoic Acid Receives Recommendation in 2025 - GlobeNewswire

Dec 19, 2025

Dec 19, 2025

Take Profit: Will Esperion Therapeutics Inc. stock maintain momentum in 2025 - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Esperion Therapeutics Inc. stock hit record highs againJuly 2025 Macro Moves & AI Powered Market Entry Strategies - Улправда

Dec 19, 2025

Dec 18, 2025

Esperion Therapeutics Q3 2025 Earnings Preview - MSN

Dec 18, 2025

Dec 18, 2025

[Form 4] Esperion Therapeutics, Inc. Insider Trading Activity - Stock Titan

Dec 18, 2025

Dec 18, 2025

Esperion Therapeutics (ESPR) CEO files Form 4 for 48,244-share tax sale - Stock Titan

Dec 18, 2025

Dec 18, 2025

Esperion Therapeutics (NASDAQ:ESPR) General Counsel Sells $23,917.39 in Stock - MarketBeat

Dec 18, 2025

Dec 18, 2025

Esperion Therapeutics (NASDAQ:ESPR) CFO Benjamin Halladay Sells 7,337 Shares - MarketBeat

Dec 18, 2025

Dec 18, 2025

Esperion Therapeutics Executives Sell Shares to Satisfy Tax Obligations - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

CFO Halladay Surrenders 7,337 Of Esperion Therapeutics Inc [ESPR] - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

Esperion Therapeutics (ESPR) CFO reports 7,337-share sale for tax obligations - Stock Titan

Dec 18, 2025

Dec 18, 2025

Aug Macro: Will Esperion Therapeutics Inc. (0ET) stock outperform value peers2025 EndofYear Setup & Community Verified Swing Trade Signals - ulpravda.ru

Dec 18, 2025

Dec 17, 2025

Officer Looker Files To Sell 6,517 Of Esperion Therapeutics Inc [ESPR] - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

PFE6265887 Bond Analysis — Key Metrics - TradingView — Track All Markets

Dec 17, 2025

Dec 15, 2025

Investors Purchase High Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat

Dec 15, 2025

Dec 12, 2025

Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month HighShould You Buy? - MarketBeat

Dec 12, 2025

Dec 11, 2025

Esperion’s Stock Surge: Opportunity Knocks?​ - StocksToTrade

Dec 11, 2025

Dec 10, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sahm

Dec 10, 2025

Dec 09, 2025

Why The Narrative Around Esperion Therapeutics Is Shifting After Analyst Upgrades And Trial Results - Yahoo Finance

Dec 09, 2025

Dec 09, 2025

Esperion announces inducement grants under Nasdaq Listing Rule - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Esperion Grants Stock Options and RSUs to New Chief Commercial Officer and Employees - Quiver Quantitative

Dec 09, 2025

Dec 06, 2025

Esperion Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 06, 2025

Dec 05, 2025

Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR - MarketBeat

Dec 05, 2025

Dec 05, 2025

Will Esperion Therapeutics Inc. (0ET) stock enhance shareholder valueEarnings Overview Summary & Smart Money Movement Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Esperion stock hits fair value target with 77% gain since April 2024 - Investing.com Australia

Dec 04, 2025

Dec 03, 2025

Esperion Therapeutics, Inc.Common Stock (Nasdaq:ESPR) Stock Quote - Markets Financial Content

Dec 03, 2025

Dec 03, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 03, 2025

Dec 03, 2025

Is Esperion Therapeutics Inc. (0ET) stock a top dividend aristocrat candidateTrend Reversal & Stepwise Trade Execution Plans - Newser

Dec 03, 2025

Dec 02, 2025

ESPR SEC FilingsEsperion Therape 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 02, 2025

Nov 27, 2025

Esperion Therapeutics (NASDAQ:ESPR) Trading 6% HigherHere's What Happened - MarketBeat

Nov 27, 2025

Nov 27, 2025

Esperion a new overweight at Piper Sandler on CV franchise - MSN

Nov 27, 2025

Nov 26, 2025

Traders Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat

Nov 26, 2025

Nov 26, 2025

Esperion Therapeutics (NASDAQ:ESPR) Coverage Initiated at Piper Sandler - MarketBeat

Nov 26, 2025

Nov 26, 2025

Esperion Therapeutics Stock Hits Near 1-Year High As Wall Street Sees Strong Risk-Reward Play On Demand For Cholesterol Drug - Stocktwits

Nov 26, 2025

Nov 25, 2025

Esperion Therapeutics: Soaring Momentum Observed - StocksToTrade

Nov 25, 2025

Nov 25, 2025

Piper Sandler Initiates Coverage of Esperion Therapeutics (ESPR) with Overweight Recommendation - Nasdaq

Nov 25, 2025

Nov 25, 2025

Piper Sandler initiates Esperion Therapeutics stock with Overweight rating By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

Esperion’s Strategic Moves: What It Means? - StocksToTrade

Nov 25, 2025

Nov 25, 2025

Esperion Therapeutics Shares Rise After Piper Sandler Initiates Coverage - marketscreener.com

Nov 25, 2025

Nov 25, 2025

Esperion Stock Grows Amid Promising Japanese Partnership and Q3 Earnings - timothysykes.com

Nov 25, 2025

Nov 25, 2025

Why Analysts Are Rewriting Esperion’s Story After New Pipeline Results and Global Partnerships - Yahoo Finance

Nov 25, 2025

Nov 25, 2025

Esperion gains after Piper Sandler initiates with 'overweight' rating - TradingView

Nov 25, 2025